In view of the plans made by national health authorities in every country across the world for the widespread vaccination of individuals against the SARS-CoV-2 virus, the Thalassaemia International Federation herein presents the latest information concerning the to-date authorized vaccinations, as well as the Federation’s position about the vaccination of patients with haemoglobin disorders against SARS-CoV-2.
BREAKING NEWS | Bluebird’s Gene Therapy For β-Thalassaemia Wins US Approval
17 Αυγούστου, 2022
SAFER BLOOD | EU Patients Have Begun Receiving Transfusions With Hemanext ONE® RBC Processing & Storage System
8 Σεπτεμβρίου, 2022